Thursday, June 22, 2023 3:17:20 PM
You don't think more notes are being issued right now? We'll find out under the next Q. Their history says there's consistent dilution to fund operations. Funded by raises to the AS.
I'll agree that they've kept dilution somewhat manageable assuming they can keep interest and make progress towards their claimed objectives.
I'll agree that they've kept dilution somewhat manageable assuming they can keep interest and make progress towards their claimed objectives.
Recent BDPT News
- BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery • GlobeNewswire Inc. • 05/20/2026 08:15:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:16:04 PM
- BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night • GlobeNewswire Inc. • 04/28/2026 02:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/14/2026 08:05:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 02:45:46 AM
- BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing • GlobeNewswire Inc. • 10/07/2025 03:48:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 07:16:01 PM
